Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double Blind, Phase III Study of BAT1706 Versus EU Avastin® Plus Chemotherapy in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

NCT03329911 is registered in ClinicalTrials.gov with Bio-Thera Solutions as lead sponsor.

NCT NCT03329911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03329911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double Blind, Phase III Study of BAT1706 Versus EU Avastin® Plus Chemotherapy in Patients With Advanced Non Squamous Non Small Cell Lung Cancer
Lead sponsor
Bio-Thera Solutions
Phase
Phase 3
Overall status
Completed
Start date
October 20, 2017
Completion date
May 27, 2021
Enrollment
651 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous non-small cell lung cancer